Controversies in obesity, 2014: |
|
Gastric bypass reduces fat intake and preference. |
|
Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy |
|
GLP-1 and glucagon secretion from a pancreatic neuroendocrine tumor causing diabetes and hyperinsulinemic hypoglycemia. |
|
Gut adaptation after metabolic surgery and its influences on the brain, liver and cancer |
|
The gut-brain axis in obesity |
|
The gut hormone response following Roux-en-Y gastric bypass: cross-sectional and prospective study |
|
Gut hypertrophy after gastric bypass is associated with increased glucagon-like peptide 2 and intestinal crypt cell proliferation. |
|
Heart remodelling and obesity: the complexities and variation of cardiac geometry |
|
High density lipoprotein in patients with liver failure; relation to sepsis, adrenal function and outcome of illness |
|
How long should we make the biliopancreatic limb during Roux-en-Y gastric bypass? |
|
Impact of Duodenal-Jejunal Exclusion on Satiety Hormones. |
|
Impact of perioperative management of glycemia in severely obese diabetic patients undergoing gastric bypass surgery. |
|
Improved blood pressure, nitric oxide and asymmetric dimethylarginine are independent after bariatric surgery. |
|
Improvements in the metabolic milieu following Roux-en-Y gastric bypass and the arrest of diabetic kidney disease. |
|
Improving patient waiting times: a simulation study of an obesity care service. |
|
Increased energy expenditure in gastric bypass rats is not caused by activated brown adipose tissue |
|
Influence of adherence to the national guidance on nutrition screening and dietitian referral on clinical outcomes of those requiring parenteral nutrition |
|
The influence of skeletal muscle on appetite regulation |
|
Is a 0900-h serum cortisol useful prior to a short synacthen test in outpatient assessment? |
|
Joint international consensus statement for ending stigma of obesity |
|
Leptin/adiponectin ratio in patients with coronary heart disease: comparing subjects with and without metabolic syndrome |
|
Lessons learned from gastric bypass operations in rats. |
|
The longest-surviving patient with classical maple syrup urine disease |
|
Maternal C-reactive protein in early pregnancy. |
|
Mechanisms of disease: the role of gastrointestinal hormones in appetite and obesity. |
|
The mechanisms of weight loss after bariatric surgery. |
|
Metabolic phenotype-microRNA data fusion analysis of the systemic consequences of Roux-en-Y gastric bypass surgery |
|
Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. |
|
Metabolic surgery: shifting the focus from glycaemia and weight to end-organ health |
|
Neuropsychometric outcome predictors for adults with maple syrup urine disease |
|
A new antiglycolytic agent |
|
A novel technique of Roux-en-Y gastric bypass reversal for postprandial hyperinsulinemic hypoglycaemia: A case report. |
|
Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding. |
|
Obesity, gut hormones, and bariatric surgery. |
|
Pancreatic polypeptide meal response may predict gastric band-induced weight loss. |
|
Peptide YY, appetite and food intake. |
|
Physiological adaptations following Roux-en-Y gastric bypass and the identification of targets for bariatric mimetic pharmacotherapy |
|
Physiological and pathophysiological signalling between the gut and the kidney: role in diabetic kidney disease |
|
Postprandial bone turnover is independent of calories above 250 kcal |
|
Postprandial plasma ghrelin is suppressed proportional to meal calorie content in normal-weight but not obese subjects. |
|
Predicting refeeding hypophosphataemia: insulin growth factor 1 (IGF-1) as a diagnostic biochemical marker for clinical practice |
|
The putative satiety hormone PYY is raised in cardiac cachexia associated with primary pulmonary hypertension |
|
Rats fed diets with different energy contribution from fat do not differ in adiposity |
|
The relationship between postprandial bile acid concentration, GLP-1, PYY and ghrelin |
|
Remission and progression of pre-existing micro- and macroalbuminuria over 15 years after bariatric surgery in Swedish Obese Subjects study |
|
Renal cytokines improve early after bariatric surgery |
|
Reply: Bariatric surgery and chronic kidney disease: much hope, but proof is still awaited |
|
A retrospective assessment of the effectiveness of fenofibrate 267 mg on high-density lipoprotein cholesterol levels in patients attending a lipid clinic |
|
The role of bariatric surgery in the treatment of diabetes. |
|
Role of proximal gut exclusion from food on glucose homeostasis in patients with Type 2 diabetes |
|
Roux-en-Y Gastric Bypass and Vertical Banded Gastroplasty Induce Long-Term Changes on the Human Gut Microbiome Contributing to Fat Mass Regulation. |
|
Roux-en-Y gastric bypass in rats increases sucrose taste-related motivated behavior independent of pharmacological GLP-1-receptor modulation. |
|
Roux-en Y gastric bypass is superior to duodeno-jejunal bypass in improving glycaemic control in Zucker diabetic fatty rats. |
|
Roux-en-Y gastric bypass surgery in rats alters gut microbiota profile along the intestine |
|
Roux-en-Y Gastric Bypass Surgery Increases Respiratory Quotient and Energy Expenditure during Food Intake. |
|
Roux-en-Y Gastric Bypass Surgery Induces Early Plasma Metabolomic and Lipidomic Alterations in Humans Associated with Diabetes Remission |
|
The satiety hormone peptide YY as a regulator of appetite. |
|
Serum total cortisol and free cortisol index give different information regarding the hypothalamus-pituitary-adrenal axis reserve in patients with liver impairment |
|
Sir David Cuthbertson Medal Lecture. Bariatric surgery as a model to study appetite control |
|
Supraphysiological doses of intravenous PYY 3-36 cause nausea, but no additional reduction in food intake |
|
Temporal changes in bile acid levels and 12α-hydroxylation after Roux-en-Y gastric bypass surgery in type 2 diabetes. |
|
Type 2 diabetes mellitus and microvascular complications 1 year after Roux-en-Y gastric bypass: a case-control study |
|
Type 2 diabetes: multimodal treatment of a complex disease. |
|
Upper gastrointestinal investigations before gastric banding. |
|
Urine bile acids relate to glucose control in patients with type 2 diabetes mellitus and a body mass index below 30 kg/m2 |
|
Vertical sleeve gastrectomy in adolescents reduces the appetitive reward value of a sweet and fatty reinforcer in a progressive ratio task |
|
Weight loss interventions and progression of diabetic kidney disease |
|
When the brakes came off: re-feeding oedema after deflation of a gastric band: a case report |
|
Where to begin and where to end? Preoperative assessment for patients undergoing metabolic surgery |
|
Why do patients lose weight after Roux-en-Y gastric bypass? |
|